When organizations treat data as a strategic asset, they can transform into analytic-driven leaders, gaining significant advantage within their highly competitive industry.
Big Data Analytics is a top priority for most companies hoping to derive new insights from all data available to improve daily operations and engage a personalized relationship with their patients.
A Big Data ecosystem allows to explore a larger number of hypothesis in a shorter timeframe, to make data available for the biostatisticians or for the accident road analysts in self-service, to prevent failures before they occur and to seize new business opportunities.
Healthcare and Car Manufacturing are 2 different markets, facing a hyper-competitive global market, fueled by stratospheric development cost and highly demanding business requirements and customer expectations as well as strong regulations.
Different but similar! For sure, they face most of the same challenges while sharing a clear focus on their community (patient care and car drivers safety), a strong DNA for innovations and a new way to unlock information empowering their business users and changing the market perspectives.
Roche and Volvo both embraced a « think-big » strategy to integrated small and big data, to analyze complex volume of data, to reduce the time to actions, to discover new areas or to infuse innovations with an agile analytical ecosystem.
They are both successfully using a Teradata Analytical Platform to fulfill the company’s strategy.
« Looking for « doing now what patients need next », Roche believes that it’s urgent to deliver medical solutions right now – even as they develop innovations for the future.
Their chairman Christoph Franz states: “Curiosity and novelty in new ideas and to question the status quo is what sets Roche apart from others.”
“Big data will play a major role in digitization of healthcare. We believe that the wealth of data will play a major role in advancing research, clinical studies and patient care.”
The vision for Roche: « Accelerate the drug development timeline » with integrated data, data analytics and data re-use.
Roche developed GLIDE (Global Integrated Drug Development Environment), a next generation data architecture.
Multiple internal and external data sources are brought into the Teradata integrated data platform, including:
• Trial data/new treatment data (usually in a SAS data set);
• Lab data – blood, ECG, X-Ray;
• Genetics data;
• Electronic data records;
• Insurance claims; and
• Medical data.
A lot of explorative analytics are now performed in a high performing environment, with Real World Data, and the ability to share results and data with other collaborators within the same environment.
These data and new capabilities leads Roche to:
• Predictive modeling to target medicines to individual patients depending on genomic information,
• Easier repurposing of drugs through the mining of treated patients and their outcomes,
• Real-time drug trials
• Flexible fast capture management and analytics of medical data
To learn more from Roche, please listen their testimonial video by clicking on the this link.
Volvo Cars has always being focused on the human being, with a commitment to safety and the environment, by « keeping drivers safe and cars designed around you ».
« Our vision is that by 2020 no one should be killed or seriously injured in a new Volvo car. » – Håkan Samuelsson, President and CEO, Volvo Cars
“We had at that point in time, a Chief Operating Officer in the company that saw the real benefits of integrating data and it was pretty much his decision. With his drive, we actually got through the first steps. Then we had the fundamentals to start to build on and we’re continuously doing so. But, that was the crucial part to get him as a supporter in the beginning.” – Jan Wassén, Director of Business Analytics.
Originally Volvo Cars took 15 years of usage and diagnostic data – combining those two huge data sources was a game changer for Volvo design, diagnostics and warranty parts of the business.
At Volvo, the Teradata system integrates product configuration, warranty, and vehicle diagnostic data, real life data to support technical and business analyses throughout the product lifecycle.
“We have taken it step-by-step. We try to not just learn what has happened, but why it’s happened and also to predict what will happen. It’s like steps in analytics we would like to follow to be more precise and actually to deliver value to the corporation. In order to do that, we needed to bring in different types of data. We started with warranty data, but also customer data comes pretty soon and there are also other types of financial data, etc., that we were trying to introduce into the warehouse for us to be able to deliver more value.” – Jan Wassén, Director of Business Analytics
The ready availability of current, quality-controlled data is transforming decision-making processes throughout the organization, with beneficial impacts on quality, warranty costs, customer satisfaction, and bottom line profitability.
Each new car is built using the knowledge gained from its predecessors – a process of continuous refinement and improvement called the Circle of Life.
These data available for the whole company contributes to various business challenges that all contributes to their safety goals and customer experience:
• Predictive Maintenance,
• Early Warning,
• Warranty Analytics,
• Active Safety Research (sensor fusion),
• Connected Car
• Weekly Hazard Analysis,
• Customer Experience,
• Vehicle to Vehicle Communication
• and Project 26.
To learn more from Volvo, please listen their testimonial video by clicking on this link.
Many companies look at analytics to isolate a specific problem. With Teradata, they can process millions of various patient/customer/product/therapeutic area combinations. Most complex companies are performing predictive analytics for one business unit, product line or geography with multiple data systems. However, having deployed a Teradata integrated environment lets Roche and Volvo do predictive analysis globally across multiple product lines and lines of business in a faster and more impactful manner.
Roche & Volvo have built a strong foundation as a data-driven organization, developing a multi-subject, enterprise-wide data environment able to deliver significant value for a myriad of industry challenges like:
• Sales and marketing analytics
• Managed markets analytics
• Research and development
• Regulatory and compliance reporting
• Supply chain management
• Data-driven finance
Patrice Bouexel is Life Sciences Account Director at Teradata
Patrice is a member of the Healthcare Data Institute.